A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (clinicaltrials.gov) - Sep 15, 2026 - P1/2 | N=204 | Not yet recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
New P1/2 trial • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|